Centene Raises Profit Outlook as Cost Cuts Overcome Client Losses

2026-10-28 companies

St. Louis, Wednesday, 28 October 2026.
Centene beat earnings expectations nearly sixfold in the third quarter of 2026, lifting its annual profit outlook through aggressive cost controls despite losing millions of insured members.

Quarterly Earnings Surge Despite Membership Declines

Centene Corporation (NYSE: CNC) delivered a financial rebound in Q3 2026, reporting adjusted diluted earnings per share of $0.58—nearly six times the $0.10 consensus estimate—while posting a net loss of $71 million due to restructuring costs [1][2][4][5][6]. Revenue for the quarter reached $50.65 billion, exceeding expectations of $47.11 billion [1][2][4][5]. The managed care giant, which serves Medicaid, Medicare, and Health Insurance Marketplace members, saw its shares rise approximately 2% on October 28, 2026, after initially volatile market reactions to the earnings release [1][2][5]. While total at-risk membership declined to 25.7 million from 28 million a year earlier, the company’s disciplined cost management and strategic repositioning drove margin improvements across its core businesses [1][2][4][5].

Cost Controls Drive Margin Recovery

Centene’s recovery reflects targeted cost-cutting initiatives, including workforce reductions from 59,800 to 53,900 employees over three months and a focus on high-margin contracts [1][2][4][5]. The company’s Health Benefits Ratio (HBR)—a key measure of medical costs relative to premiums—stabilized at 92.7% in Q3 2026, down from 93.5% projected earlier in the year [2][4][5]. Adjusted selling, general, and administrative (SG&A) expenses fell to 6.5%, a 50-basis-point improvement from Q2 2026 [2][4][5]. Medicare revenue surged 20% year-over-year to $11.26 billion, driven by a 12% increase in prescription drug plan (PDP) enrollment [1][2]. However, Medicaid margins remained under pressure, with an HBR of 93.6%, though this represented a sequential improvement from prior quarters [2][4][5].

Leadership Highlights Strategic Shifts

Centene CEO Sarah London emphasized the company’s progress in stabilizing core businesses, noting that ‘solid underlying fundamentals within our core businesses have powered a faster recovery to our earnings trajectory than previously anticipated’ [2][4][5][6]. The company’s debt reduction program, which repurchased $1.1 billion in senior notes since Q2 2026, lowered total debt to $15.0 billion—down from $18.5 billion at the end of 2024 [2][4][5]. London also highlighted Medicaid’s long-term potential, stating, ‘Ultimately, we see significant opportunity for margin restoration and sustainable long-term growth in Medicaid’ [4][6]. Her remarks followed a challenging 2025 marked by medical cost surges and premium shortfalls, which the company has addressed through rate increases and budget discipline [1][2][4].

Marketplace and Medicare Dynamics

Centene’s Marketplace business, which includes Affordable Care Act plans, faced enrollment declines of 42% year-over-year due to higher premiums and reduced subsidies [1][2][5]. Despite this, the segment achieved a 5% pre-tax margin in Q3 2026—up from a negative 1% in 2025—putting it at the top of its guided range [4][6]. The company expects Marketplace membership to stabilize around 3.2 million by year-end 2026, with plans to expand its product suite for 2027 open enrollment [4][6]. In Medicare Advantage, Centene reached breakeven financial results in 2026, a year ahead of schedule, supported by disciplined trend management and favorable medical cost experience [2][4][5][6]. However, the proportion of Medicare Advantage members in 4-star or higher plans halved, potentially impacting future quality bonuses under federal programs [1][2].

2026 Guidance Raised, 2027 Uncertainty Looms

Centene raised its full-year 2026 adjusted diluted EPS guidance to greater than $5.20, up from $4.80, while narrowing its revenue forecast to between $196.5 billion and $200.5 billion [2][4][5][6]. The company also improved its full-year HBR guidance to a mid-point of 90.75%, reflecting stronger-than-expected cost controls [2][4][5]. For 2027, however, visibility remains limited due to policy changes, including the expiration of enhanced Affordable Care Act subsidies and the ‘One Big Beautiful Bill Act,’ which may restrict Medicaid access [1][2][5][6]. Analysts note that Centene’s ability to sustain margins will depend on successful rate negotiations with states and its portfolio optimization strategy, which prioritizes margin expansion over membership growth [2][4][5][6]. The company is expected to issue formal 2027 guidance in February 2027 [4][6].

Sources

Managed care Medicaid enrollment